MissionIR Articles
-
eXp World Holdings, Inc. (EXPI) Creating a Legacy of Commercial and Social Impact
eXp World Holdings, Inc. (OTCQB: EXPI) is a corporation of the times and parent company to a selection of notable subsidiaries that are making a lasting impact, both commercially and socially. The most notable of…
-
Monaker Group, Inc. (MKGI) Leveraging Game-Changing Approach to the Real-Time Alternative Lodging Market
The business model proposed by Monaker Group, Inc. (OTCQB: MKGI) and the group’s innovative approach to the alternative vacation rental market are discussed in depth by leading financial news and information portal SECFilings.com (http://dtn.fm/A5Mjn). Noting…
-
Professional Diversity Network, Inc. (IPDN) Helping Shape a More Demographic-Based Workforce
With diversity being both a legal and popular factor in business, and with businesses facing a more diverse customer base, companies are making a conscious effort to develop and maintain a more culturally diverse workforce.…
-
National Waste Management Holdings, Inc. (NWMH) Protects the Environment with a Range of Green Services
In the ‘Advancing Sustainable Materials Management: 2014 Fact Sheet’ (http://dtn.fm/JH1hf) published last month, the U.S. Environmental Protection Agency (EPA) released statistics on the amount of municipal solid waste (MSW) and construction and demolition (C&D) debris…
-
Cellceutix Corp. (CTIX) Advances Pipeline toward Multi-billion Dollar Opportunities, Piques Peer Interest along the Way
Cellceutix (OTCQB: CTIX) CEO Leo Ehrlich in September issued a fiscal year-end business statement recapping the company’s ability to usher its three unique compounds through various stages of clinical trials to successfully meet primary endpoints…
-
Heron Therapeutics (HRTX) Helps Chemo Patients Prevent Vomiting with SUSTOL®
Cancer is the great scourge of our age. This year, 1.7 million Americans will find out they have the disease and some 600,000 will die from it. In total, approximately 40 percent of the population…
-
Neuralstem, Inc. (CUR) Gets Aegis Update
Neuralstem, Inc. (NASDAQ: CUR) is a biotechnology company whose patented technology allows for the production, on a commercial level, of a number of types of central nervous stem cells. These are in the development stage…
-
European Patent Dispute Spurs Buying Opportunity with Higher Price Target for Alder Biopharmaceuticals (ALDR)
A legal dispute with the European Patent Office over the European patent for its lead product candidate surprisingly presents a strong buying opportunity for clinical stage biopharmaceutical company Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), according to…
-
Momenta Pharmaceuticals, Inc. (MNTA) is “One to Watch”
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) is a biotechnology company focused on the development of generic versions of complex drugs. The company is in the business of discovering and developing new therapies for oncology and autoimmune…
-
Fortress Biotech, Inc. (FBIO) set to Profit from Profuse Product Portfolio
Fortress Biotech, Inc. (NASDAQ: FBIO) is not putting all its eggs in one basket. This is a biopharmaceutical company with multiple revenue streams and a profuse product portfolio so diversified that Harry Markowitz, the father…
-
Akebia Therapeutics (AKBA) ‘Buy’ Rating Reiterated with Higher Stock Price Target of $18
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharma company that focuses on the development of innovative treatments for chronic kidney disease-related anemia, is maintaining its ‘Buy’ rating, with a recommended stock price target of $18 compared…
-
National Waste Management Holdings, Inc. (NWMH) Plans Further Growth with Targeted Acquisitions
In its latest quarterly report (10-Q), National Waste Management Holdings (OTC: NWMH), a solid waste management company headquartered in central Florida, demonstrated impressive growth. The company is currently running at full speed to achieve its…
-
Zogenix, Inc. (ZGNX) Develops Orphan Drug for Dravet Syndrome Epilepsy
Zogenix, Inc (NASDAQ: ZGNX) is a clinical stage pharmaceutical company committed to the development and commercialization of therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases. The…
-
Matinas BioPharma Holdings, Inc. (MTNB) is “One to Watch”
Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), is a biopharmaceutical company still in its clinical stages, focused on identifying and developing treatments for fungal and bacterial infections. Founded in 2012, the company’s goal is to change…
-
Monaker Group, Inc. (MKGI) and Recruiter.com Announce Launch of Custom Travel Rewards Club
Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced the launch of a new travel service and loyalty program as part of its ongoing partnership with Recruiter.com, a leading global recruiting service and job…
-
Dynagas LNG Partners LP (DLNG) is “One to Watch”
According to a past article on MarketWatch (http://dtn.fm/ruK1O), after the Fukushima nuclear disaster there was an increase in liquefied natural gas (LNG) demand in 2012. This meant that the LNG carrier fleet was operating at…
Search Articles
Latest Articles
- A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Advancing Retail Innovation Through AI-Powered Smart-Cart Technology
- Forward Industries Inc. (NASDAQ: FWDI) Positive Update for Shareholders After Debuting the Company’s Solana Treasury Strategy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Secures Funding to Strengthen North American Supply Chain
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast